﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://www.apotex.com/global/contact-us/corporate-purchasing</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/media-relations</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/legal/legal-and-copyright-terms</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/global-reach</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/canadian-sales</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/careers/our-winning-culture</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/martin-ares</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/careers/working-with-us</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/international-corporate-development</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/stories-of-resilience</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/portfolio/consumer-health</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/portfolio/innovative-specialty-medicines</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/portfolio</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/portfolio/biosimilars</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/francesco-tallarico</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/carina-vassilieva</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-purpose</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/home</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/barry-fishman</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/jeff-watson</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/partnerships/business-development-inquiries</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/careers</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/kiran-krishnan</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/ariel-alon</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/international-customer-service</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/dispedia</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/international-business-development</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/christine-baeder</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/legal/privacy-policy</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/corporate-communications</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/portfolio/generics</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/adverse-reaction-contact-information</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/united-states-customer-service-sales</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/global-manufacturing-excellence</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/webmaster</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/ethics-and-compliance</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/pradeep-sanghvi</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-leadership/brian-mcclelland</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/partnerships</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/about-us/our-impact</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/contact-us/privacy-officer</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2017/06/12/apobiologix-applauds-supreme-court-decision-in-sandoz-biosimilar-case</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2017/06/08/canadian-scientists-honored-for-role-in-breakthrough-drug</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2017/04/28/university-of-saskatchewan-apotex-renew-partnership-with-dollars-1-6m-donation-to-the-college-of-pharmacy-and-nutrition</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2017/03/08/apotex-announces-dollars-184-million-investment-to-grow-us-manufacturing-presence-expansion-plan-comprises-companys-largest-investment-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2016/03/31/launch-of-key-biosimilar-medicine-to-help-save-healthcare-budgets</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2016/03/24/apotex-launches-first-generic-version-of-mercks-nasonex</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/03/05/apotex-statement-drug-supply-and-covid-19</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/03/23/apotex-donates-hydroxychloroquine-for-a-clinical-study-to-prevent-infection-from-covid-19-with-front-line-health-care-workers</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/04/13/canada-s-largest-pharmaceutical-company-produces-hand-sanitizer-to-support-the-fight-against-covid-19</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/04/17/canada-s-apotex-donates-critical-n95-masks-to-support-frontline-healthcare-workers</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/04/21/canada-s-apotex-donates-two-million-dosages-of-hydroxychloroquine-to-the-public-health-agency-of-canada</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/05/25/toronto-company-launches-hiring-blitz-during-covid-19</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/05/26/canada-s-largest-pharmaceutical-manufacturer-donates-thousands-of-bottles-of-hand-sanitizer-to-hospitals-across-quebec</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2020/05/26/apotex-corp-donates-critical-medicines-in-the-fight-against-covid-19</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2021/02/02/apotex-corp.-issues-voluntary-nationwide-recall-of-enoxaparin-sodium-injection-usp-due-to-mislabeling-of-syringe-barrel-measurement-markings</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2022/04/12/apotex-corp-launches-generic-of-abraxane-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2022/05/17/apotex-launches-affordable-generic-option-to-treat-relapsing-remitting-multiple-sclerosis</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2022/07/20/first-generic-alternative-to-eliquis-now-available-in-canada</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2022/09/28/sk-capital-to-acquire-apotex-a-global-leader-in-affordable-pharmaceuticals</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2023/04/03/sk-capital-completes-acquisition-of-apotex-a-global-leader-in-affordable-pharmaceuticals</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2023/04/19/apotex-receives-fda-s-drug-shortage-assistance-award</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/02/16/harrow-licenses-canadian-rights-to-apotex-for-five-branded-ophthalmic-pharmaceutical-products</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/04/02/apotex-to-acquire-searchlight-pharma--a-canadian-specialty-branded-pharmaceutical-leader</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/06/03/apotex-completes-acquisition-of-searchlight-a-leading-canadian-based-specialty-innovative-branded-pharmaceutical-company</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/07/03/apotex-further-expands-oncology-franchise-through-the-acquisition-of-canadian-rights-to-toripalimab</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/08/07/apotex-expands-ophthalmic-franchise-through-the-acquisition-of-canadian-rights-to-app13007-clobetasol-propionate-ophthalmic-suspension--0-05---a-novel-steroid-for-ophthalmology</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/02/03/apotex-enters-the-growing-canadian-health-and-wellness-sector-through-the-acquisition-of-canprev--a-leading-canadian-natural-health-company</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/07/apotex-announces-expansion-of-licensing-agreement-with-formosa-pharmaceuticals-to-mexico-for-commercialization-of-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-inflammation-and-pain-following-ocular-surgery</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/13/apotex-announces-launch-of-the-apotex-global-health-access-fund-to-promote-health-equity-with--250-000-in-annual-funding-to-the-rexdale-community-health-centre</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/13/apotex-announces-grant-to-healthy-mothers--healthy-babies-coalition-of-broward-county-to-promote-maternal-health-with--242-000-in-annual-funding</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/13/apotex-announces--100-000-in-annual-funding-to-advance-maternal-and-infant-health-in-mexico</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/13/apotex-announces-grant-to-foundation-for-mother-and-child-health-to-promote-maternal-health-with-cad--100-000-in-annual-funding</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/20/apotex-publishes-2024-sustainability-report--highlighting-progress-and-achievements-in-environmentally-sustainable-manufacturing--responsible-business-practices--and-social-impact</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/07/02/apotex-receives-health-canada-approval-for-aflivu---a-biosimilar-to-eylea---available-in-pre-filled-syringe-and-vial-formats</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/25/apotex-launches-nilotinib-capsules--the-first-generic-version-of-tasigna---in-the-united-states--with-180-days-of-exclusivity</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/05/09/apotex-introduces-ivra--melphalan-hydrochloride-injection--first-ready-to-dilute-liquid-formulation-of-melphalan-injection-approved-via-505b2-nda-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/02/05/apotex-acquires-us-rights-to-provigil--modafinil-and-nuvigil--armodafinil</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/02/05/apotex--through-its-specialty-pharma-division--searchlight--expands-branded-dermatology-portfolio-through-the-in-licensing-of-the-canadian-rights-to-seysara--sarecycline-and-finjuve--finasteride</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/02/24/apotex-licenses-exclusive-canadian-rights-to-qutenza--from-grunenthal</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/09/05/apotex-corp-is-the-first-generic-manufacturer-to-launch-dasatinib-tablets-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/09/05/apotex-corp-is-the-first-generic-manufacturer-to-launch-oxcarbazepine-er-tablets-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2024/05/15/apotex-corp-launches-generic-fertility-treatment-injectable-cetrorelix--in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2023/11/21/apotex-corp-launches-teriparatide-injectable-for-osteoporosis-treatment-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2023/09/05/apotex-corp-launches-brimonidine-tartrate-ophthalmic-solution--0-1--in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2023/08/26/apotex-corp.-launches-bendamustine-hydrochloride-injection-in-the-united-states</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/10/07/apotex-strengthens-commitment-to-womens-health-with-exclusive-canadian-rights-to-linzagolix-for-uterine-fibroid-treatment</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/10/08/apotex-supports-launch-of-home-based-cancer-care-with-1-5m-donation</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/10/23/apotex-receives-health-canada-approval-for-loqtorzi-the-first-and-only-immuno-therapy-for-recurrent-unresectable-or-metastatic-nasopharyngeal-cancer</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2025/11/17/apotex-donation-helps-oak-valley-health-respond-to-urgent-capacity-needs-amid-rapid-community-growth</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/02/05/apotex-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido--from-grunenthal</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/03/25/apotex-expands-canadian-ophthalmology-portfolio-with-health-canada-s-approval-of-clobivis--(clobetasol-propionate-ophthalmic-suspension--0.05-)</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/03/30/apotex-announces-leadership-changes</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/04/07/apotex-strengthens-osteoporosis-care-in-canada-with-health-canada-s-approval-of-denoza-a-denosumab-biosimilar</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/04/10/apotex-receives-first-us-fda-tentative-approval-for-a-generic-version-of-ozempic-semaglutide-injection-in-partnership-with-orbicular</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/04/14/apotex-announces-fda-approval-of-first-generic-infuvite-adult-injection-single-dose-vial-and-pharmacy-bulk-package-with-180-day-cgt-exclusivity-for-the-pharmacy-bulk-package-in-partnership-with-orbicular-and-gland-pharma</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/04/23/apotex-announces-strategic-transaction-with-cumberland-pharmaceuticals-to-integrate-their-u.s.-branded-businesses</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/04/27/apotex-announces-fda-approval-of-generic-infuvite-pediatric-injection-eligible-for-180-day-cgt-exclusivity-single-dose-vial-complementing-its-recent-approval-of-generic-infuvite-adult-injection</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/05/01/apotex-becomes-the-first-canadian-based-global-pharmaceutical-company-to-receive-health-canada-approval-for-a-generic-equivalent-of-ozempic</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/05/14/apotex-launches-apo-semaglutide-injection-a-generic-equivalent-of-ozempic-in-canada</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/05/26/apotex-expands-ophthalmic-portfolio-with-health-canada-approval-of-iheezo</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/05/28/apotex-health-corp-files-preliminary-prospectus-for-initial-public-offering</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/01/apotex-health-corp-launches-its-initial-public-offering</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/03/apotex-launches-sitagliptin-tablets-and-sitagliptin-and-metformin-hydrochloride-tablets-eligible-for-180-day-shared-exclusivity</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/09/apotex-health-corp-upsizes-its-initial-public-offering</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/10/apotex-health-corp-files-final-prospectus-and-announces-pricing-of-upsized-initial-public-offering</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/16/apotex-health-corp-announces-closing-of-upsized-initial-public-offering-and-exercise-of-over-allotment-option-in-full</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/06/30/apotex-first-to-receive-health-canada-approval-for-sevmia-a-generic-semaglutide-for-chronic-weight-management</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/07/01/apotex-completes-previously-announced-strategic-transaction-with-cumberland-pharmaceuticals</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/07/08/apotex-expands-us-hospital-portfolio-with-launch-of-generic-infuvite-adult-and-pediatric-injection</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/07/17/apotex-receives-investment-grade-issuer-rating-from-morningstar-dbrs-and-announces-amended-restated-credit-agreement</loc>
    <priority>1</priority>
  </url>
  <url>
    <loc>https://www.apotex.com/global/news/news-release/2026/08/12/apotex-announces-first-quarter-2027-results</loc>
    <priority>1</priority>
  </url>
</urlset>